SCHEMBL1032086

SCHEMBL1032086

O=C1C[C@H](O)[C@H](O)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21350260 1.00
SCHEMBL3394564 1.00
SCHEMBL14601490 0.78
SCHEMBL13577729 0.78
SCHEMBL7816966 0.78
SCHEMBL52211 0.76
SCHEMBL574767 0.76
SCHEMBL3277293 0.76
SCHEMBL31536825 0.75 LMNA (0.39)
SCHEMBL14601499 0.73 CYP2D6 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546083-B2 Molecular accessibility assay UNIVERSITY OF VERMONT (US) 2013-10-01 US claimed
US-20100047791-A1 MOLECULAR ACCESSIBILITY ASSAY NATIONAL INSTITUTES OF HEALTH 2010-02-25 US claimed
WO-2008091541-A1 MOLECULAR ACCESSIBILITY ASSAY UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) 2008-07-31 WO claimed
EP-4720331-A1 FALSE POSITIVE REDUCTION BY TRANSLESION POLYMERASE REPAIR Illumina, Inc. (US) 2026-04-08 EP disclosed
EP-4705313-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS The Scripps Research Institute (US) 2026-03-11 EP disclosed
WO-2024249466-A1 FALSE POSITIVE REDUCTION BY TRANSLESION POLYMERASE REPAIR ILLUMINA, INC. (US) 2024-12-05 WO disclosed
WO-2024227159-A2 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS THE SCRIPPS RESEARCH INSTITUTE (US) 2024-10-31 WO disclosed
CN-104755469-B The manufacture method of difluoro ester compounds 旭硝子株式会社 2018-04-10 CN disclosed
US-20170334941-A1 2',2'-DIHALO NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER EMORY UNIVERSITY 2017-11-23 US disclosed
US-9790252-B2 2-fluorinated riboses and arabinoses and methods of use and synthesis CORNELL UNIVERSITY (US) 2017-10-17 US disclosed
EP-3212658-A1 2',2'-DIHALO NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER Cocrystal Pharma, Inc. (US) 2017-09-06 EP disclosed
US-20050112555-A1 Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-05-26 US disclosed
WO-2005023985-A2 CYTIDINE DEAMINASE ACTIVATORS, DEOXYCYTIDINE DEAMINASE ACTIVATORS, VIF ANTAGONISTS, AND METHODS OF SCREENING FOR MOLECULES THEREOF UNIVERSITY OF ROCHESTER (US) 2005-03-17 WO disclosed
US-20050054042-A1 Novel gluconate dehydratase MITSUI CHEMICALS, INC. (JP) 2005-03-10 US disclosed
EP-1496113-A1 Gluconate dehydratase MITSUI CHEMICALS, INC. (JP) 2005-01-12 EP disclosed
WO-2004113358-A1 PRODUCTION OF 2'-DEOXYNUCLEOSIDES AND 2'-DEOXYNUCLEOSIDE PRECURSORS FROM 2-DEHYDRO-3-DEOXY-D-GLUCONATE EVOLOGIC S.A. (FR) 2004-12-29 WO disclosed
WO-2001072698-A1 OPTICALLY ACTIVE CYANOBUTANTRIOL DERIVATIVES AND PROCESS FOR PREPARING SAME KUKJE PHARMA. IND. CO., LTD. (KR) 2001-10-04 WO disclosed
US-5721350-A Deuterated nucleosides CHATTOPADHYAYA JYOTI (SE) 1998-02-24 US disclosed
EP-0648220-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA, Jyoti (SE) 1995-04-19 EP disclosed
WO-1993025566-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA JYOTI (SE) 1993-12-23 WO disclosed